GNH USA

Europe — EMA

Lamivudin/Zidovudin Accord (Zidovudine, Lamivudine)

GNH USA supplies Lamivudin/Zidovudin Accord (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV‑1 infection.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudine and Zidovudine, the active ingredients in Lamivudin/Zidovudin Accord, are nucleoside reverse transcriptase inhibitors presented as a fixed‑dose oral tablet for oral use. They are employed in the management of HIV‑1 infection in adults, children, and pregnant women, and are part of standard combination regimens recommended by the WHO.

GNH USA supplies Lamivudin/Zidovudin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for antiretroviral therapies across global markets.

What is Zidovudine, Lamivudine used for?

Lamivudin/Zidovudin Accord is used in antiretroviral therapy targeting HIV‑1 infection.

- HIV‑1 infection (adults): reduces plasma viral load and helps restore CD4+ T‑cell counts in treatment‑naïve adults. - HIV‑1 infection (children): provides age‑appropriate dosing to control viral replication in pediatric patients. - HIV‑1 infection (pregnant women): used to decrease maternal viral load and reduce the risk of mother‑to‑child transmission.

What are the side effects of Zidovudine, Lamivudine?

Lamivudin/Zidovudin Accord may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Fatigue: general tiredness. - Diarrhea: loose stools. - Anemia: mild reduction in hemoglobin. - Elevated liver enzymes: mild transaminase increase.

Serious or Rare Side Effects: - Severe neutropenia: marked decrease in neutrophil count. - Lactic acidosis: rare metabolic complication. - Hepatotoxicity: significant liver injury. - Pancreatitis: inflammation of the pancreas. - Stevens‑Johnson syndrome: severe skin reaction.

What precautions apply to Zidovudine, Lamivudine?

When prescribing Lamivudin/Zidovudin Accord, clinicians should consider several precautionary measures to ensure safe use.

- Baseline laboratory tests: obtain CBC, liver function, and renal function before initiation. - Monitoring: perform regular CBC and liver enzyme assessments during therapy. - Pregnancy: weigh benefits against potential risks; use only if clearly needed. - Drug resistance: avoid in patients with documented resistance to lamivudine or zidovudine. - Concomitant hepatotoxic drugs: use with caution when combined with other agents that affect liver. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

What does Zidovudine, Lamivudine interact with?

Lamivudin/Zidovudin Accord can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis and mitochondrial toxicity. - Stavudine: heightened potential for peripheral neuropathy and lactic acidosis. - Efavirenz: may reduce plasma concentrations of zidovudine.

Moderate Interactions (Monitor Closely): - Ribavirin: additive hematologic toxicity, monitor blood counts. - Mycophenolate mofetil: possible enhanced bone marrow suppression. - Non‑nucleoside reverse transcriptase inhibitors (e.g., nevirapine): may affect drug levels, require monitoring.

Frequently asked questions

What is Lamivudin/Zidovudin Accord used for?+
Lamivudin/Zidovudin Accord is a fixed‑dose combination of lamivudine and zidovudine indicated for the treatment of HIV‑1 infection. It is used as part of combination antiretroviral therapy to lower viral load, improve immune function, and reduce the risk of disease progression in adults, children, and pregnant women.
How does lamivudine and zidovudine work?+
Both lamivudine and zidovudine are nucleoside analogues that, once phosphorylated inside cells, mimic natural nucleosides. They are incorporated into the viral DNA by HIV reverse transcriptase, but lack a 3′‑hydroxyl group, causing premature chain termination and preventing the virus from completing its replication cycle.
What is the usual dose of Lamivudin/Zidovudin Accord?+
The dosing regimen for Lamivudin/Zidovudin Accord is individualized and must be determined by a qualified healthcare professional based on the patient’s age, weight, renal function, and overall treatment plan. Prescribers follow current clinical guidelines and adjust the dose as needed.
Is Lamivudin/Zidovudin Accord safe during pregnancy or breastfeeding?+
Lamivudin/Zidovudin Accord may be prescribed to pregnant or breastfeeding women when the expected benefits outweigh potential risks. Clinical data suggest that the benefits of controlling maternal HIV infection and preventing vertical transmission generally justify use, but the decision should be made in consultation with a specialist.
How do I order Lamivudin/Zidovudin Accord from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.
How does this combination compare with other antiretroviral options?+
Lamivudin/Zidovudin Accord offers a convenient fixed‑dose option that combines two nucleoside reverse transcriptase inhibitors, simplifying regimen complexity compared with separate tablets. While newer agents may have improved resistance profiles, this combination remains a cost‑effective backbone in many WHO‑recommended regimens, especially in resource‑limited settings.
How should Lamivudin/Zidovudin Accord be stored and handled?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect from moisture and direct sunlight, and ensure the packaging remains sealed until use. Do not store in a refrigerator or freezer.
How is Lamivudin/Zidovudin Accord administered?+
The medication is taken orally, usually with or without food, as directed by the prescribing clinician. Patients should swallow the tablet whole with a full glass of water and follow the dosing schedule provided on the prescription label.
What are the most serious risks to watch for while taking Lamivudin/Zidovudin Accord?+
Serious adverse events include severe neutropenia, lactic acidosis, hepatotoxicity, pancreatitis, and rare hypersensitivity reactions such as Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience symptoms like unexplained fatigue, abdominal pain, rapid breathing, jaundice, or severe skin rash.
Who should not use Lamivudin/Zidovudin Accord?+
The combination should be avoided in individuals with known hypersensitivity to lamivudine, zidovudine, or any excipients in the tablet. It is also contraindicated in patients with documented resistance to either component and in those with severe bone marrow suppression unless benefits clearly outweigh risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Accord Healthcare B.V.
Origin
EU

Related products

Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU
Combivir

Combivir

Zidovudine, Lamivudine

Viiv Healthcare B.V.
EU